Anti-HAI-1 Rabbit Polyclonal Antibody
- Host
- Rabbit, Polyclonal
- Reactivity
- Validated- Human Potential-Mouse, Rat, Pan, Monkey, Dog
- UniProt
- O43278
- Size
- 100ug
- Cat. #
- RP3HAI1
In stock
- SKU
- RP-HAI1
Target Overview
Hepatocyte growth factor activator inhibitor type 1 (HAI-1), encoded by the SPINT1 gene (UniProt O43278), is a 529-residue Kunitz-type transmembrane serine protease inhibitor. HAI-1 is a secreted protein that functions as a critical regulator of extracellular proteolytic cascades. It inhibits the serine protease activity of HGFAC (hepatocyte growth factor activator), ST14/matriptase, and TMPRSS13, with inhibition of the latter mediated through its BPTI/Kunitz inhibitor 1 domain. HAI-1 is widely expressed in epithelial tissues and plays essential roles in regulating cellular processes including growth factor activation, epithelial integrity, and protease-dependent signaling. Dysregulation of HAI-1 expression has been implicated in cancer progression, particularly in epithelial malignancies where protease balance governs invasion and metastasis. Researchers study HAI-1 to understand protease inhibitor networks, epithelial homeostasis, and the molecular mechanisms underlying tumor microenvironment remodeling.
Background
References
- Saeed AK et al (2026) The role of HAI-1 in urothelial bladder cancer: Tissue expression, ectodomain shedding and clinical outcomes. Biochem Biophys Rep. PubMed · 10.1016/j.bbrep.2026.102600
- Murakami R (2026) Morphological and Molecular Characteristics of Choroid Plexus Epithelium in Aged Brains. Int J Mol Sci. PubMed · 10.3390/ijms27052505
- Chen CY et al (2026) Membrane-Anchored Serine Protease Inhibitors: Physiological Functions, Mechanisms, and Roles in Cancer. Int J Mol Sci. PubMed · 10.3390/ijms27042000
- Silva TA et al (2026) Proteomic Profiling of Non-Muscle Invasive Bladder Cancer Reveals Potential Biomarkers for Recurrence and Progression Risk. J Proteome Res. PubMed · 10.1021/acs.jproteome.5c00486
Additional Specifications
| Gene Symbol | SPINT1 |
|---|---|
| UniProt ID | O43278 |
| Host Species | Rabbit |
| Species Reactivity | Validated- Human Potential-Mouse, Rat, Pan, Monkey, Dog |
| Pack Size | 100ug |
| Immunogen (aminoterminal end mature HAI-1) | Immunogen is proprietary and confidential. Immunogen generated in amino acid region 36-86. |
| Immunogen (KD1 insert) | Immunogen is proprietary and confidential. Immunogen generated in amino acid region 179-261. |
| Immunogen (Cytoplasmic domain) | Immunogen is proprietary and confidential. Immunogen generated in amino acid region 505-529. |
| Alternate Names | HAI-1, Hepatocyte growth factor activator inhibitor type 1, SPINT1, Kunitz-type protease inhibitor 1, Serine protease inhibitor Kunitz-type 1 |
Frequently Asked Questions
What molecular weight should I expect for HAI-1 on Western blot?
HAI-1 migrates at approximately 58-66 kDa on Western blot, which is higher than the predicted molecular weight of the 529-residue polypeptide due to N-linked glycosylation. You may observe multiple bands representing differentially glycosylated forms or proteolytic fragments. Some cell types also produce a cleaved, secreted form of HAI-1 lacking the transmembrane domain, which migrates slightly faster. Reducing conditions are recommended to disrupt any disulfide-linked complexes with target proteases like matriptase, which can shift the apparent molecular weight upward.
What is the recommended starting dilution for HAI-1 antibody in Western blot?
Start at 1:1000 dilution in blocking buffer containing 5 percent non-fat milk or BSA for overnight incubation at 4°C. This dilution has been validated with whole-cell lysates from epithelial cell lines expressing endogenous HAI-1. If signal is weak in your specific lysate, you can increase concentration to 1:500. Conversely, high-expressing samples may tolerate 1:2000. Always include a positive control lysate from a HAI-1-expressing epithelial cell line such as HaCaT or Caco-2 to confirm antibody performance before troubleshooting.
Does this antibody recognize HAI-1 in mouse and rat samples?
This antibody has validated reactivity against human HAI-1. Cross-reactivity with mouse and rat HAI-1 is predicted based on sequence homology in the immunogen region but has not been experimentally validated by Triple Point Biologics. Human and mouse HAI-1 share approximately 80 percent sequence identity. If you are working with rodent samples, plan to include a positive control from mouse or rat epithelial tissue and be prepared to optimize dilution. Some researchers report successful detection in mouse samples at similar working dilutions to human.
What are good positive and negative control cell lines for HAI-1 expression?
HAI-1 is widely expressed in epithelial cells, so keratinocytes (HaCaT), intestinal epithelial cells (Caco-2, HT-29), and prostate epithelial lines (LNCaP, PC-3) serve as reliable positive controls. Hepatocyte-derived cell lines like HepG2 also express moderate to high levels. For negative controls, consider mesenchymal or hematopoietic cells, though truly HAI-1-null lines are uncommon given its broad epithelial expression pattern. Alternatively, use siRNA knockdown in a positive cell line to confirm antibody specificity and establish the expected band shift on your blot.
Can this antibody detect HAI-1 in immunofluorescence or immunohistochemistry?
Triple Point Biologics antibodies are validated for Western blot and immunohistochemistry. This rabbit polyclonal should perform well in IHC on formalin-fixed paraffin-embedded tissue sections; antigen retrieval with citrate buffer (pH 6.0) is typically effective for HAI-1. For immunofluorescence on cultured cells, start with a 1:100 to 1:200 dilution after fixation with 4 percent paraformaldehyde and permeabilization with 0.1 percent Triton X-100. HAI-1 localizes to the plasma membrane and cytoplasm in epithelial cells, so expect punctate membrane staining with some intracellular signal.
Does HAI-1 form complexes with proteases that affect antibody detection?
Yes. HAI-1 forms tight, SDS-stable complexes with its target serine proteases, particularly matriptase (ST14) and HGFAC. Under non-reducing conditions, you may detect high-molecular-weight bands corresponding to HAI-1-protease complexes in addition to the free HAI-1 monomer. If you are specifically interested in the free inhibitor pool, run samples under reducing conditions with dithiothreitol or beta-mercaptoethanol to disrupt disulfide linkages. Conversely, non-reducing gels can provide insight into the extent of protease inhibition and complex formation in your experimental system.
How should I store the HAI-1 antibody and how long is it stable?
Store the antibody at -20°C in single-use aliquots to avoid repeated freeze-thaw cycles, which can reduce titre and increase background. The antibody is supplied at 100 µg in a glycerol-containing buffer that remains stable for at least 12 months at -20°C. For frequent use, keep a working aliquot at 4°C with 0.02 percent sodium azide; this remains stable for several weeks. Avoid prolonged storage at 4°C without preservative. Do not store diluted antibody in blocking buffer for more than one week, as carrier proteins can degrade and increase non-specific binding.
Why is HAI-1 expression important in epithelial cancer research?
HAI-1 acts as a tumor suppressor in many epithelial cancers by inhibiting matriptase and hepatocyte growth factor activator, proteases that promote invasive growth and metastasis. Loss or downregulation of HAI-1 is associated with increased tumor aggressiveness in gastric, colorectal, ovarian, and prostate cancers. Conversely, maintaining HAI-1 expression preserves epithelial barrier integrity and restrains protease-driven signaling cascades. When designing cancer cell experiments, monitor HAI-1 levels alongside its target proteases to understand the balance of proteolytic regulation. Dysregulated HAI-1 can serve as a prognostic marker in patient-derived samples.
Western blot validation for RP-HAI1 — 3 panels across the domain-specific antibody variants. Each blot below shows the clone that validates a specific domain of the target protein.
Custom validation studies available on request — contact us.
Also known as:
- HAI-1
- Hepatocyte growth factor activator inhibitor type 1
- SPINT1
- Kunitz-type protease inhibitor 1
- Serine protease inhibitor Kunitz-type 1